Curasight doses first patient in Phase I brain cancer trial of uTREAT
The study is designed to assess uTREAT as a targeted radiopharmaceutical therapy in patients newly diagnosed with GBM.
Medical Devices
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
Zimmer Biomet and OneStep to deliver digital mobility analytics in orthopaedics
Thermedical treats first patient in trial of SERF ablation system for VT
FDA approves Dilon’s intraoperative margin assessment device
Helio Genomics and LiverRight team up for early detection of liver cancer
